title: Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
authors.affiliation: Vancouver Hospital, Vancouver, BC, Canada. mancini@interchange.ubc.ca
authors.forename: G B John
authors.initials: GB
authors.lastname: Mancini
authors.forename: Michael E
authors.initials: ME
authors.lastname: Miller
authors.forename: Gregory W
authors.initials: GW
authors.lastname: Evans
authors.forename: Robert
authors.initials: R
authors.lastname: Byington
authors.forename: Curt D
authors.initials: CD
authors.lastname: Furberg
authors.forename: Bertram
authors.initials: B
authors.lastname: Pitt
mesh_terms: D017311:Amlodipine / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003327:Coronary Disease / Q000188:drug therapy*; D023903:Coronary Restenosis; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D002121:Calcium Channel Blockers; D017311:Amlodipine